These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32779880)

  • 1. Impact of Home Confinement During the COVID-19 Pandemic on Medication Use and Disease Activity in Spondyloarthritis Patients.
    Roux CH; Brocq O; Gerald F; Pradier C; Bailly L
    Arthritis Rheumatol; 2020 Oct; 72(10):1771-1772. PubMed ID: 32779880
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical impact of COVID-19 on a French population of spondyloarthritis patients.
    Roux CH; Brocq O; Gerald F; Pradier C; Bailly L
    Clin Rheumatol; 2020 Nov; 39(11):3185-3187. PubMed ID: 32970219
    [No Abstract]   [Full Text] [Related]  

  • 3. Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?
    Mease PJ
    Nat Rev Rheumatol; 2012 May; 8(5):251-2. PubMed ID: 22549279
    [No Abstract]   [Full Text] [Related]  

  • 4. Three months treatment of active spondyloarthritis with imatinib mesylate: an open-label pilot study with six patients.
    Eklund KK; Remitz A; Kautiainen H; Reitamo S; Leirisalo-Repo M
    Rheumatology (Oxford); 2006 Dec; 45(12):1573-5. PubMed ID: 17077157
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psoriatic arthritis and general recommendations for targeted therapy of spondyloarthritis].
    Märker-Hermann E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):2037-40. PubMed ID: 24065412
    [No Abstract]   [Full Text] [Related]  

  • 6. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis.
    Zochling J; Brandt J; Braun J
    Rheumatology (Oxford); 2005 Dec; 44(12):1483-91. PubMed ID: 16091395
    [No Abstract]   [Full Text] [Related]  

  • 7. Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study.
    Modesti V; Ramonda R; Ortolan A; Lorenzin M; Lo Nigro A; Frallonardo P; Oliviero F; Campana C; Punzi L
    Scand J Rheumatol; 2012; 41(6):490-1. PubMed ID: 22985209
    [No Abstract]   [Full Text] [Related]  

  • 8. [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].
    Kiltz U; Sieper J; Kellner H; Krause D; Rudwaleit M; Chenot JF; Stallmach A; Jaresch S; Braun J;
    Z Rheumatol; 2014 Sep; 73 Suppl 2():78-96. PubMed ID: 25181978
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of ACR 2010 fibromyalgia criteria fulfillment on disease activity evaluation in patients with axial spondyloarthritis treated with infliximab.
    Dantu A; Michaud J; Bréhier Q; Banse C; Avenel G; Lequerré T; Pouplin S; Vittecoq O; Verdet M
    Joint Bone Spine; 2019 Jan; 86(1):113-114. PubMed ID: 29680208
    [No Abstract]   [Full Text] [Related]  

  • 10. Spondyloarthritis: from unifying concepts to improved treatment.
    Paramarta JE; Baeten D
    Rheumatology (Oxford); 2014 Sep; 53(9):1547-59. PubMed ID: 24369419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treat to Target in Axial Spondyloarthritis: What Are the Issues?
    Danve A; Deodhar A
    Curr Rheumatol Rep; 2017 May; 19(5):22. PubMed ID: 28386759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab.
    Mease PJ; Van den Bosch F; Sieper J; Xia Y; Pangan AL; Song IH
    J Rheumatol; 2017 May; 44(5):599-608. PubMed ID: 28298558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study.
    Lubrano E; Massimo Perrotta F; Manara M; D'Angelo S; Addimanda O; Ramonda R; Punzi L; Olivieri I; Salvarani C; Marchesoni A
    J Rheumatol; 2016 Aug; 43(8):1541-6. PubMed ID: 27252428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral spondyloarthritis: Concept, diagnosis and treatment.
    Molto A; Sieper J
    Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):357-368. PubMed ID: 31171308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spondyloarthritis including psoriatic arthritis].
    Rudwaleit M; Märker-Hermann E
    Dtsch Med Wochenschr; 2011 Oct; 136(40):2033-6. PubMed ID: 21960334
    [No Abstract]   [Full Text] [Related]  

  • 16. Unanswered questions in the management of axial spondyloarthritis: an opinion piece.
    Baraliakos X; Deodhar A
    Clin Rheumatol; 2014; 33(10):1359-65. PubMed ID: 24941929
    [No Abstract]   [Full Text] [Related]  

  • 17. Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis.
    Wendling D; Goupille P
    Immunotherapy; 2020 Aug; 12(12):857-860. PubMed ID: 32635788
    [No Abstract]   [Full Text] [Related]  

  • 18. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D; Nowik M; Gremese E; Ferraccioli GF
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of etanercept in patients from Latin America, Central Europe and Asia with early non-radiographic axial spondyloarthritis.
    Wei JC; Tsai WC; Citera G; Kotak S; Llamado L
    Int J Rheum Dis; 2018 Jul; 21(7):1443-1451. PubMed ID: 27863065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cohort studies in spondyloarthritis.
    Rudwaleit M
    Joint Bone Spine; 2013 Mar; 80(2):127-9. PubMed ID: 23238001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.